Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
03/2006
03/08/2006EP1451167B1 Phenylalkynes
03/08/2006EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
03/08/2006EP1339723B1 Process and ester derivatives useful for preparation of cephalosporins
03/08/2006EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
03/08/2006EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
03/08/2006CN1745067A Biphenylcarboxamide compound
03/08/2006CN1743321A Method for preparing thiazolidine acetate coprising phenyl propylidene
03/08/2006CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors
03/08/2006CN1244542C Aromatic amine derivatives having NOS inhibitory effect
03/07/2006US7008957 6-amino-5-oxo--hexahydropyrrolo[2,1-b]thiazole-3-carbonitrile compounds of given formula; for the treatment of metabohlic disorders such as type 2 diabetes
03/07/2006US7008956 p53 inhibitors and therapeutic use of the same
03/07/2006US7008753 Optical recording medium
03/07/2006US7008561 Ether carboxylic acids based on alkoxylated mercaptobenzothiazoles and use of the same as corrosion inhibitors
03/02/2006WO2006023720A2 Reactions of enolizable a-amino aldehydes or ketones to form amine
03/02/2006WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity
03/02/2006WO2006022252A1 Method for producing aminothiazole derivative and production intermediate
03/02/2006WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
03/02/2006WO2006021805A1 Diarylsulfones as 5-ht2a antagonists
03/02/2006WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase
03/02/2006WO2005072132A3 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
03/02/2006US20060047123 Mercaptoamides as histone deacetylase inhibitors
03/02/2006DE102004041532A1 Biphenylthiazolcarboxamide Biphenyl thiazole carboxamides
03/02/2006DE102004041530A1 Biphenylthiazolcarboxamide Biphenyl thiazole carboxamides
03/02/2006CA2838123A1 Method for producing aminothiazole derivative and production intermediate
03/02/2006CA2577846A1 Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
03/02/2006CA2577837A1 Diarylsulfones as 5-ht2a antagonists
03/02/2006CA2576469A1 Method for producing aminothiazole derivative and production intermediate
03/01/2006EP1630157A1 CaSR ANTAGONIST
03/01/2006EP1630152A1 Condensed ring compound
03/01/2006EP1629842A1 Topical application of thiazolyl amides
03/01/2006EP1628687A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers
03/01/2006EP1628666A2 Compouds and uses thereof in modulating amyloid beta
03/01/2006EP1628662A1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
03/01/2006EP1628661A2 Modulators of vr1 receptor
03/01/2006EP1462451B1 Novel crystalline forms of meloxicam and the preparation and interconversion methods thereof
03/01/2006EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases
03/01/2006EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions
03/01/2006EP1098638B1 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart
03/01/2006EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors
03/01/2006CN1742010A Novel chemical compounds
03/01/2006CN1741802A Propargyl-trifluoromethoxy-amino-benzothiazole derivatives
03/01/2006CN1243741C Quinolinyl and benzothiazolyc PPAR-gamma modulators
03/01/2006CN1243740C Alpha-form or beta-form crystal of acetanilide derivative
03/01/2006CN1243739C Method for production of 1,3-disubstituted 2-nitroguanidines
03/01/2006CN1243724C Amide derivatives which are useful as cell factor inhibitors
03/01/2006CN1243545C DNA-cleaving antitumor agents
02/2006
02/28/2006US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism
02/28/2006US7005440 Therapeutic uses of tri-aryl acid derivatives
02/23/2006WO2005110980A3 Aryl sulfones and uses related thereto
02/23/2006WO2005048953A3 Amide derivatives as kinase modulators
02/23/2006US20060040998 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof
02/23/2006US20060040997 Benzthiazole-3 oxides useful for the treatment of proliferative disorders
02/23/2006US20060040996 Administering compound such as 5 {[2-(dimethylamino)ethyl]amino}-2-methyl-1,3-benzothiazole-4,7-dione
02/23/2006US20060040992 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
02/23/2006CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
02/23/2006CA2575466A1 Thiazole based inhibitors of atp-utilizing enzymes
02/23/2006CA2574279A1 Heterocyclic compounds as pharmaceutical agents
02/23/2006CA2573772A1 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
02/22/2006EP1627869A1 Amide derivative
02/22/2006EP1627635A2 Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection
02/22/2006EP1626962A1 Benzamide inhibitors of the p2x7 receptor
02/22/2006CN1738808A Cyclization process for substituted benzothiazole derivatives
02/22/2006CN1738799A Methods for preparing phenylalkyne derivatives
02/22/2006CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication
02/22/2006CN1242998C Process of recovering 2-mercaptan benzothiazole from cefotaxime producing slag
02/21/2006US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety
02/21/2006US7002019 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones
02/21/2006US7001916 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
02/21/2006US7001909 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease
02/21/2006US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
02/21/2006CA2337846C Polymorph of ritonavir
02/16/2006WO2006016218A1 Aryl or heteroaryl carbonyl derivatives derivatives useful as vanilloid receptor 1 (vr1) antagonists
02/16/2006WO2006016174A1 Fluorination process of protected aminothiazole
02/16/2006WO2006016039A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
02/16/2006WO2006015859A1 Trifluoromethyl substituted benzamides as kinase inhibitors
02/16/2006WO2005080317A3 Therapeutic amide derivatives
02/16/2006WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists
02/16/2006US20060035946 Amyloid-binding, metal-chelating agents
02/16/2006US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
02/16/2006US20060035897 Trifluoromethyl substituted benzamides as kinase inhibitors
02/16/2006US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase
02/16/2006CA2575430A1 1,3-disubstituted heteroaryl nmda/nr2b antagonists
02/16/2006CA2575316A1 Trifluoromethyl substituted benzamides as kinase inhibitors
02/16/2006CA2573509A1 Histone deacetylase inhibitors
02/16/2006CA2571143A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
02/15/2006EP1625122A1 Dipeptidyl peptidase inhibitors
02/15/2006EP1625112A1 Novel compounds for treatment of obesity
02/15/2006CN1735604A Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole
02/15/2006CN1735598A Phenyl or heteroaryl amino alkane derivatives as IP receptor antagonist
02/15/2006CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity
02/15/2006CN1733699A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
02/14/2006US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties
02/14/2006US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
02/14/2006US6998412 Heterocyclic compounds
02/14/2006US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic
02/14/2006US6997961 N-heteroarylmethyl-m-phenylenediamine derivatives-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives
02/09/2006WO2006013445A2 Thiazolidinedione derivatives as alpha adrenergic receptor antagonists
02/09/2006US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
02/09/2006US20060030709 PNA monomer and precursor
02/09/2006US20060030657 Use of sulfur containing initiators for anionic polymerization of monomers